speb/financial-data huggingface dataset:
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 158979261.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 2900000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 2900000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 300000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 300000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 592700000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 592700000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 48400000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 48400000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 10700000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 100000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 100000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: -100000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: -100000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 7600000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 45900000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 991400000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 465200000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Other Payable: 71400000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 71400000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Other Properties: 1841600000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 1841600000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 97800000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 97800000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 1740800000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 1740800000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Other Special Charges: -100000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Payables: 835200000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Payables: 835200000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 161800000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 161800000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Pretax Income: 1454400000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 471900000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 12600000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Purchase Of Business: -112600000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -65600000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -334800000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 446300000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 446300000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 1911600000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 494700000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 552600000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 137700000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 18100000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 18100000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -215900000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 1700000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 1700000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 3146300000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 3146300000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Sale Of Business: 100000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 82000000.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 100000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 403000000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 774200000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Share Issued: 158980353.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 158980353.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Special Income Charges: 100000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
THYROCARE.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 245100000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 5467600000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 5467600000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 4337100000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 4337100000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 33165965.35
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Tax Provision: 546900000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 256200000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.38
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
THYROCARE.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -513800000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Total Assets: 6927500000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 6927500000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 5467600000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 5467600000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Total Debt: 246800000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 246800000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 5470600000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 5470600000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Total Expenses: 5449200000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 1432300000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 1456900000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1456900000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 3550300000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 3550300000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 238500000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 238500000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 6900000.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 23800000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 23800000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 88200000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 88200000.00
THYROCARE.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Treasury Shares Number: 1092.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 1092.00
THYROCARE.NS balance_sheet (annual, 2025-03-31) — Working Capital: 2158800000.00
THYROCARE.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 2158800000.00
THYROCARE.NS income_statement (annual, 2025-03-31) — Write Off: 0.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 910400000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 1930300000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 161535270.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 2.41
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 556300000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 114100000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 114100000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 162208333.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 2.40
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 389300000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — EBIT: 512600000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — EBITDA: 626700000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 1374000000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 7800000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 7800000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Minority Interests: 6400000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Net Income: 389300000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 389300000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 382900000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 389300000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 389300000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 382900000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -7800000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -7800000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 626700000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 389300000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Operating Income: 463600000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 1930300000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 46500000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 466300000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 504800000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 556300000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 114100000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 121900000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.24
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 1466700000.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
THYROCARE.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
THYROCARE.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 159082873.00
THYROCARE.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 3.02
THYROCARE.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 159435216.00
THYROCARE.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 3.01
THYROCARE.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 158983341.00
THYROCARE.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 158983341.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 1121300000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 1955300000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 159395604.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 1.82
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 472000000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 216300000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 216300000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 160276243.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.81
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 290100000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — EBIT: 362000000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — EBITDA: 578300000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 1483300000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Interest Income: 900000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 900000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 9600000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Net Income: 290100000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 290100000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 280500000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 290100000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 290100000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 280500000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: 900000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 900000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 639900000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 338923961.57
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Operating Income: 362000000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 1955300000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 49800000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 547400000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 353900000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 472000000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 216300000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -61600000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -12776038.43
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 73400000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 1593300000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -61600000.00
THYROCARE.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -61600000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — +Operating Expense: 3976700000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 1062100000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — +Total Revenue: 8218900000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 2239500000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 653700000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 653700000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 738800000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 738800000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -2782300000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -2782300000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 38300000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 38300000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -62900000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -62900000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Amortization: 12700000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Amortization Cash Flow: 12700000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 66600000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 66600000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 159144432.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 157591973.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Basic EPS: 10.24
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 2.99
THYROCARE.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 176800000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 857700000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 857700000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -208800000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 506900000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 506900000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 1591700000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1591700000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 383200000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 383200000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2311300000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2311300000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -1484300000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 383200000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 383200000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -19200000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: 27400000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: -30500000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Change In Payable: -108600000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -9900000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -84600000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 206400000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Common Stock: 1591700000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 1591700000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Common Stock Dividend Paid: -1484300000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 5855000000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 5855000000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 0.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 30700000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 30700000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 2195700000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 566800000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Current Assets: 3722900000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 3722900000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 115100000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 115100000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 115100000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 115100000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Current Deferred Taxes Liabilities: 23800000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Current Deferred Taxes Liabilities: 23800000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 1099100000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1099100000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 14600000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 14600000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Depreciation: 573100000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 585800000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 585800000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 140300000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 573100000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 140300000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 159633477.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 158120805.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Diluted EPS: 10.21
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 2.98
THYROCARE.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 1630400000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 471200000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Dividends Payable: 2200000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 2200000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — EBIT: 2156800000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — EBIT: 659500000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — EBITDA: 2742600000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — EBITDA: 799800000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — End Cash Position: 383200000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -1695900000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Finished Goods: 21700000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 21700000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 1923600000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -77100000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -40900000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 393200000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Goodwill: 1082100000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 1082100000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 1118000000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 1118000000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 801700000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 801700000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 4869100000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 4869100000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Gross Profit: 6023200000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 1672700000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Interest Expense: 28000000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 15200000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 28000000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 15200000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Interest Income: 34000000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 34000000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -27700000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 30700000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Inventory: 484600000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 484600000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 5855000000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 5855000000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -230100000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 0.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 0.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Investmentsin Associatesat Cost: 251400000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Investmentsin Associatesat Cost: 251400000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 0.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 317200000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 317200000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 391800000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 391800000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 391800000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 391800000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: 0.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 251400000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 251400000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 121100000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 121100000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 3663500000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 3663500000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 5200000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 5200000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Minority Interests: 1900000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Minority Interests: -15900000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: 0.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 0.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Net Income: 1630400000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Net Income: 471200000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 1630400000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 471200000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 1628500000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 487000000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1630400000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 471200000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1630400000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 471200000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 2128800000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 1628500000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 487000000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Net Interest Income: -5600000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -15200000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -106000000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 0.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 0.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -5600000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -15200000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Net PPE: 2086800000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 2086800000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -154800000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 4737000000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 4737000000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 156600000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 156600000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 121100000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 121100000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 137500000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 137500000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 2686300000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 799800000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Normalized Income: 1587331346.30
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 471200000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 2132400000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Operating Income: 2046500000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Operating Income: 610600000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Operating Revenue: 8218900000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 2239500000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 159161691.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 159161691.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 11300000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 11300000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 40500000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 40500000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 794600000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 794600000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 35900000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 35900000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -3700000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: -1000000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: -1000000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 18000000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 43100000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 1122000000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 561100000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Other Payable: 51700000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 51700000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Other Properties: 2056200000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 2056200000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 81300000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 81300000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 1928100000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 1928100000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Other Special Charges: 20800000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Payables: 707600000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Payables: 707600000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 93400000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 93400000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Pretax Income: 2128800000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 644300000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Properties: 0.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: -18700000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: 0.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -106000000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -208800000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Raw Materials: 462900000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Raw Materials: 462900000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 2195700000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 566800000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 585800000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 140300000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 17800000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 17800000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: 0.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Restricted Cash: 2200000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 2200000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 1333900000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 1333900000.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Sale Of Business: 0.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 54000000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 548800000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 942000000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Share Issued: 159165315.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 159165315.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Special Income Charges: -20800000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
THYROCARE.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 240900000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 5855000000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 5855000000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 4737000000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 4737000000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 13231346.30
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Tax Provision: 500300000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 157300000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.24
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.24
THYROCARE.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -598200000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Total Assets: 7472200000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 7472200000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 5855000000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 5855000000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Total Debt: 506900000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 506900000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 5860200000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 5860200000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Total Expenses: 6172400000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 1628900000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 1612000000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1612000000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 3749300000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 3749300000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 512900000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 512900000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Total Other Finance Cost: 11600000.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 23800000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 23800000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 56300000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 56300000.00
THYROCARE.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Treasury Shares Number: 3624.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 3624.00
THYROCARE.NS balance_sheet (annual, 2026-03-31) — Working Capital: 2623800000.00
THYROCARE.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 2623800000.00
THYROCARE.NS income_statement (annual, 2026-03-31) — Write Off: 0.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — +Operating Expense: 1130700000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — +Total Revenue: 2400200000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Basic Average Shares: 161578947.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Basic EPS: 3.23
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Cost Of Revenue: 621600000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Depreciation And Amortization In Income Statement: 124900000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Depreciation Income Statement: 124900000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Diluted Average Shares: 162080745.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Diluted EPS: 3.22
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Diluted NI Availto Com Stockholders: 521900000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — EBIT: 696400000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — EBITDA: 821300000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Gross Profit: 1778600000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Interest Expense: 13500000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Interest Expense Non Operating: 13500000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Minority Interests: 8600000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Net Income: 521900000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Net Income Common Stockholders: 521900000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Net Income Continuous Operations: 513300000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Net Income From Continuing And Discontinued Operation: 521900000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Net Income From Continuing Operation Net Minority Interest: 521900000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Net Income Including Noncontrolling Interests: 513300000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Net Interest Income: -13500000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Net Non Operating Interest Income Expense: -13500000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Normalized EBITDA: 821300000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Normalized Income: 521900000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Operating Income: 647900000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Operating Revenue: 2400200000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Other Non Operating Income Expenses: 41500000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Other Operating Expenses: 609800000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Otherunder Preferred Stock Dividend: 0.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Pretax Income: 682900000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Reconciled Cost Of Revenue: 621600000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Reconciled Depreciation: 124900000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Special Income Charges: 0.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Tax Effect Of Unusual Items: 0.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Tax Provision: 169600000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Tax Rate For Calcs: 0.25
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Total Expenses: 1752300000.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Total Unusual Items: 0.00
THYROCARE.NS income_statement (quarterly, 2026-06-30) — Total Unusual Items Excluding Goodwill: 0.00
TI.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -3592734000.00
TI.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 2969961000.00
TI.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -76677000.00
TI.NS income_statement (annual, 2022-03-31) — Amortization: 377000.00
TI.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 377000.00
TI.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 143451429.00
TI.NS income_statement (annual, 2022-03-31) — Basic EPS: 3.15
TI.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 1036329000.00
TI.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 7395000.00
TI.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 420006000.00
TI.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 253395000.00
TI.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 146711688.00
TI.NS income_statement (annual, 2022-03-31) — Diluted EPS: 3.08
TI.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 0.00
TI.NS cash_flow (annual, 2022-03-31) — Dividends Received Cfi: 0.00
TI.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 349534000.00
TI.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 77805000.00
TI.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 2444337000.00
TI.NS income_statement (annual, 2022-03-31) — Interest Income: 17507000.00
TI.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 17507000.00
TI.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 1388085000.00
TI.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 5371641000.00
TI.NS income_statement (annual, 2022-03-31) — Minority Interests: 0.00
TI.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: -246398000.00
TI.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 0.00
TI.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 320631000.00
TI.NS balance_sheet (annual, 2022-03-31) — Other Non Current Liabilities: 145250000.00
TI.NS balance_sheet (annual, 2022-03-31) — Other Payable: 232455000.00
TI.NS income_statement (annual, 2022-03-31) — Other Special Charges: -132263000.00
TI.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 9503000.00
TI.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 235432000.00
TI.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
TI.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 337976000.00
TI.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 1269000.00
TI.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 1269000.00
TI.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 0.00
TI.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: -3551428000.00
TI.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 1535154000.00
TI.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 1612959000.00
TI.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 130906000.00
TI.NS balance_sheet (annual, 2022-03-31) — Total Tax Payable: 0.00